次世代の革新的薬物動態研究へのアプローチ

[1st P-01] Potential usability of cancer-type OATP1B3 as a diagnostic biomarker for human colon cancer

^○Yuchen Sun ¹, Tomomi Furihata ¹, Manami Harada ¹, Osamu Shimozato ², Hiroaki Souda ³, Nobuhiro Takiguchi ³, Yoshihiro Nabeya ³, Takehiko Kamijo ⁴, Naoto Yamaguchi ⁵, Kan Chiba ¹ (1.Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University, 2.Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, 3.Department of Gastrointestinal Surgery, Chiba Cancer Center Hospital, 4.Division of Biochemistry and Molecular Carcinogenesis, Chiba Cancer Center Research Institute, 5.Laboratory of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University)

Organizers:Takumi Tomono(Laboratory of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare), Yutaro Hoshi(Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University), Chairs:Armania Nurdin(Division of Membrane Transport and Drug Targeting, Graduate school of Pharmaceutical Science, Tohoku University), Takeshi Susukida(The Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Science, Chiba University)